This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Ucb Pharma Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Nader Boshta: Innovator in Pharmaceutical Chemistry
Introduction
Nader Boshta is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Nader holds a patent for "Pyridinyl and pyrazinyl-(asa)indolsulfonamides." This invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides that exhibit GPR17 modulator activity. The compounds developed by Nader have potential utility in treating various GPR17-associated disorders. He has 1 patent to his name.
Career Highlights
Nader is currently employed at UCB Pharma GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that can address unmet medical needs.
Collaborations
Some of Nader's coworkers include Marie Ledecq and Cécile Pegurier, who collaborate with him on various research projects.
Conclusion
Nader Boshta's work in pharmaceutical chemistry exemplifies the impact of innovative thinking in developing new treatments for complex disorders. His contributions are paving the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile